Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sifalimumab (1 trial)
Lupus Erythematosus, Systemic (Phase 2)
Trials (1 total)
Trial APIs (1 total)